Picture of Carna Biosciences logo

4572 — Carna Biosciences News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapMomentum Trap

Table: Garna Biosciences -2023 group results

Feb 9 (Reuters)- 
          Garna Biosciences Inc 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended        Year to         NEXT   
              Dec 31, 2023    Dec 31, 2022     Dec 31, 2024      YEAR     
                 LATEST         YEAR-AGO         COMPANY        COMPANY   
                 RESULTS         RESULTS         FORECAST     H1 FORECAST 
  Sales           1.63            1.39           925 mln                  
               (+17.2 pct)     (-31.3 pct)     (-43.0 pct)                
  Operating     loss 1.12       loss 1.27       loss 2.20                 
  Recurring     loss 1.13       loss 1.28       loss 2.21                 
  Net
  Net           loss 1.15       loss 1.35       loss 2.23                 
  EPS        loss 68.62 yen  loss 99.10 yen  loss 129.81 yen              
  Ann Div          NIL             NIL             NIL                    
  -Q2 Div          NIL             NIL             NIL                    
  -Q4 Div          NIL             NIL             NIL                    
  
  NOTE - Garna Biosciences Inc.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4572.T

Recent news on Carna Biosciences

See all news